Definitive Contract HHSN268200460255C
Award Date 9/30/04
Potential Completion Date 1/15/07
Potential Value $916K
Funding Federal Agency
Not listed Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Israel
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Decode Genetics, Inc. The contract is for "POPULATION GENETICS ANALYSIS IMMUNITY TO VACCINES/INFECTIONS" and has a total ceiling value of $25,044,463.33. The contract is a definitive contract with a cost-no-fee pricing type and does not have a set-aside designation. The period of performance runs from the award date of...
- This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Human Genome Research Institute to Genedx, LLC, a subsidiary of Opko Health, Inc. The $25,000.00 firm fixed-price purchase order is for the provision of genetic testing services, including mutation analysis, exome and genome sequencing, gene panel testing, and mitochondrial testing. The contract has a completion date of June 30, 2025. Genedx is the prime...
- This is a $13,875 firm-fixed-price delivery order awarded by the National Human Genome Research Institute (NHGRI), a civilian agency within the U.S. Department of Health and Human Services, to The Johns Hopkins University to provide high-throughput genotyping and DNA sequencing services for studying the genetic contributions to human health and disease. The work is part of the Global Diversity Array + PGx (pharmacogenomics) initiative for NHGRI. The contract has an ultimate completion date of...
- This is a $171,198.03 firm fixed-price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to the Translational Genomics Research Institute (TGen), a non-profit biomedical research organization based in Phoenix, Arizona. The contract is for a pilot study to investigate how sex differences in early life contribute to the developmental origins of...
- This firm fixed-price purchase order was awarded by the Office of the Chief Operating Officer (a civilian agency), a component of the National Institutes of Health (NIH), to Genedx, LLC, a for-profit limited liability company. The $81,666 contract is for medical laboratory testing services, specifically genetic testing and diagnostic services. Genedx, a wholly owned subsidiary of Opko Health, Inc., provides comprehensive genetic testing, including mutation analysis, exome and genome...
- This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Genedx, LLC, a leading provider of genetic testing and diagnostic services. The contract, valued at $75,395.00, provides for a range of genetic testing services to support NIH research and clinical programs, including mutation analysis, exome and genome sequencing, gene panel testing, and mitochondrial testing. Genedx, a wholly owned subsidiary of Opko Health, Inc., has extensive...
- This federal contract award, identified as 75N92018P00220, was issued by the National Human Genome Research Institute (NHGRI), a civilian agency, to EGL Genetic Diagnostics LLC, a for-profit foreign-owned organization. The contract is for $87,249.00 and has a firm fixed price. It is to provide biochemical and molecular genetic testing services in support of the NHGRI's Undiagnosed Diseases Program. The contract has a completion date of September 11, 2019 and does not have a set-aside...
- This federal contract award, with ID HHSN269201700325PC, was issued by the National Institutes of Health (NIH) Clinical Center to Genedx, LLC, a for-profit limited liability company. The contract is for $95,385.00 and is for medical laboratory testing services, specifically supporting genetic testing and analysis. The contract is a firm fixed-price purchase order without a set-aside designation, indicating Genedx competed in the open market for this award. Genedx, as a wholly owned subsidiary of...
- This federal contract award, valued at $89,127.00, was issued by the National Institutes of Health (NIH) Clinical Center to Genedx, LLC, a for-profit limited liability company and provider of genetic testing and diagnostic services. The contract is for medical laboratory testing services, primarily supporting research and clinical programs at the NIH. Genedx holds two significant Indefinite Delivery Vehicle (IDV) contracts with the NIH Clinical Center, one of which was set aside for small...
- This is a firm fixed-price purchase order contract awarded by the Office of the Chief Operating Officer at the National Institutes of Health (NIH) to Genedx, LLC, a for-profit limited liability company, for medical laboratory testing services. The contract award, valued at $97,833.65, has a performance period from January 14, 2016, to an ultimate completion date of the same day. Genedx, a wholly owned subsidiary of Opko Health, Inc., is a leading provider of genetic testing and diagnostic...